COMT Met allele gene
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (32)
Papers in which this entity is mentioned.
- Investigation of a global mouse methylome atlas reveals subtype-specific copy number alterations in pediatric cancer models. (2026)
- Extrachromosomal DNA-Driven Oncogene Spatial Heterogeneity and Evolution in Glioblastoma. (2025)
- Meta-analysis reveals differences in somatic alterations by genetic ancestry across common cancers. (2025)
- Functional analysis of cancer-associated germline risk variants. (2025)
- Three-dimensional genome landscape of primary human cancers. (2025)
- Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy. (2024)
- RNA splicing dysregulation and the hallmarks of cancer. (2023)
- Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing. (2022)
- Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncology. (2021)
- Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA. (2020)
- Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers. (2019)
- Exploring the landscape of focal amplifications in cancer using AmpliconArchitect. (2019)
- Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer. (2018)
- Comprehensive Characterization of Cancer Driver Genes and Mutations. (2018)
- Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes. (2018)
- Copy number signatures and mutational processes in ovarian carcinoma. (2018)
- OncoKB: A Precision Oncology Knowledge Base. (2017)
- Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma. (2017)
- Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors. (2017)
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. (2017)
- Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype. (2017)
- Copy-number signatures and mutational processes in ovarian carcinoma (2017)
- Fragment Length of Circulating Tumor DNA. (2016)
- Global analysis of somatic structural genomic alterations and their impact on gene expression in diverse human cancers. (2016)
- The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies. (2016)
- Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. (2015)
- A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis. (2015)
- Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth. (2015)
- DNA-Mutation Inventory to Refine and Enhance Cancer Treatment (DIRECT): a catalog of clinically relevant cancer mutations to enable genome-directed anticancer therapy. (2013)
- Pan-cancer patterns of somatic copy number alteration. (2013)
- Patient-derived tumour xenografts as models for oncology drug development. (2012)
- Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts. (2009)
Merged raw entities (4)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| met | gene | 43 | 97 |
| comt met allele | variant | 3 | 4 |
| comt met allele | gene | — | — |
| met158 | gene | — | — |